Who we are

Altay is a team of scientists with expertise in transcription factor biology and clinical drug development. We believe in an integrated approach to drug development that includes biochemical assays, next generation computational biology and chemoproteomics. Our mission is to develop more specific and safer therapies to extend the lives of patients.

Board of Directors

Ali hidef.jpg
Eva Chin.jpg

Ali Ozes. Ph.D.
Founder, CEO & Board Member

Eva Chin. Ph.D.
Board Member

  • LinkedIn
  • LinkedIn
ERic bjerkholt.jpg

Eric Bjerkholt. MS. MBA
Chairman of the Board

  • LinkedIn

Scientific Team

Osman Final.jpg

Osman Ozes. Ph.D.
Founder & CSO

  • LinkedIn
James Ferguson.jpg

James Ferguson. Ph.D.
Senior Scientist

  • LinkedIn
Justin Eng.jpg

Justin Eng
Research Associate

  • LinkedIn

Advisors and Collaborators

Screenshot_2021-01-21 Paul J Wolters.png
Screenshot_2021-01-21 Aykut Uren Georgetown University.png
Fran sverdrup.jpg
Kamran photo.JPG

Paul Wolters. MD.

Aykut Uren. MD.

Fran Sverdrup Ph.D.

Kamran Atabai. Ph.D.

  • LinkedIn
  • LinkedIn
  • LinkedIn


Our  location

Altay Therapeutics is located in MBC Biolabs in San Carlos in the heart of the scientific and entrepreneurial hub. We are near world-class research organizations such as the Gladstone Institute, Stanford University, University of California San Francisco and their core facilities.